NCT05295017View on ClinicalTrials.gov

LEVANTIS-0093A: GAGomes for Multi-Cancer Early Detection in High-Risk Adults (LEV93A)

Active, not recruitingOBSERVATIONAL
Enrollment

1,235

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

March 31, 2026

Conditions
Cancer
Trial Locations (1)

Unknown

Leads Teaching Hospitals Trust, Leeds

Sponsors

Lead Sponsor

Elypta
All Listed Sponsors
lead

Elypta

INDUSTRY

NCT05295017 - LEVANTIS-0093A: GAGomes for Multi-Cancer Early Detection in High-Risk Adults (LEV93A) | Biotech Hunter | Biotech Hunter